Outset Medical (OM) Research & Development (2019 - 2026)

Outset Medical (OM) has 8 years of Research & Development data on file, last reported at $13.3 million in Q1 2026.

• On a quarterly basis, Research & Development rose 140.78% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 18.59% decrease from a year earlier, with the FY2025 full-year figure at $21.2 million, down 44.7% from the prior year.
• Research & Development for Q1 2026 stood at $13.3 million, up from -$20.2 million in the prior quarter.
• Over the last five years, Research & Development for OM reached as high as $52.1 million in Q4 2022 and fell as low as -$20.2 million in Q4 2025.
• Historically, Research & Development has averaged $12.1 million across 5 years, with a median of $13.3 million in 2026.
• Across the five-year window, Research & Development surged 274.99% in 2023 and tumbled 229.24% in 2024, its largest moves.
• Year by year, Research & Development stood at $52.1 million in 2022, then sank by 75.93% to $12.5 million in 2023, then tumbled by 229.24% to -$16.2 million in 2024, then fell by 25.01% to -$20.2 million in 2025, then jumped by 165.59% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $13.3 million in Q1 2026, -$20.2 million in Q4 2025, and $5.4 million in Q3 2025.